Evenity Will Be a New Injectable for Postmenopausal Osteoporosis

June 2019

Some postmenopausal women will get Evenity (ee-VEN-ih-tee, romosozumab), a new injectable med for osteoporosis.

Evenity increases bone growth AND decreases bone breakdown. Other osteoporosis meds (alendronate, Forteo, etc) do one OR the other.

Expect Evenity to be saved for high-risk women...such as those with a prior fracture on a bisphosphonate (alendronate, etc) or with multiple back fractures.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Cannabinoids Get the Facts About Cannabidiol (CBD)
Med Administration Help Patients Overcome Med Administration Hurdles
Insomnia Listen for Reports of Strange Sleep Behaviors With Some Insomnia Meds
Menopause Be Ready to Dispense Bijuva for Hot Flashes During Menopause
Gastroenterology Don't Think of Meds as a Significant Source of Gluten
Dosage Forms Watch for Mix-Ups With Meds That Come as Both Solids and Liquids
Osteoporosis Evenity Will Be a New Injectable for Postmenopausal Osteoporosis
Opioids Take Steps to Ensure Opioid Tapers Go Safely and Smoothly
Warts Sort Through Treatments for Warts
Practice Look for Opportunities to Develop Your Leadership Skills

Evenity Will Be a New Injectable for Postmenopausal Osteoporosis

Practical advice for a better career, with unlimited access to CE

Table of Contents